A

180 Life Sciences Corp
D

ATNF

2.23000
USD
-0.02
(-0.89%)
Market Closed
Volume
12,224
EPS
-3
Div Yield
-
P/E
0
Market Cap
4,408,708
OverviewSignalsIdeasNews
Related Instruments
    A
    AHCO
    -0.40000
    (-3.98%)
    9.64000 USD
    A
    ALPN
    0
    (0%)
    0.000000 USD
    A
    ANY
    0.02000
    (1.37%)
    1.48000 USD
    B
    BCEL
    0
    (0%)
    0.000000 USD
    B
    BNGO
    -0.00920
    (-3.60%)
    0.24620 USD
    C
    CDNA
    -0.400
    (-1.86%)
    21.160 USD
    C
    CRNT
    -0.10500
    (-3.74%)
    2.70500 USD
    C
    CVM
    0.00010
    (0.02%)
    0.56020 USD
    C
    CYTH
    -0.09000
    (-12.33%)
    0.64000 USD
    D
    DTIL
    -0.07000
    (-0.91%)
    7.62000 USD
    G
    GENE
    0.03930
    (5.35%)
    0.77430 USD
    G
    GNS
    0.00670
    (0.77%)
    0.88000 USD
    K
    KERN
    0.08380
    (36.45%)
    0.31370 USD
    M
    MRTX
    0
    (0%)
    0.000000 USD
    N
    NAVB
    -0.002500
    (-3.16%)
    0.076500 USD
    O
    ONCS
    -0.01000
    (-0.44%)
    2.16000 USD
    O
    ONVO
    -0.02940
    (-8.35%)
    0.32270 USD
    P
    PPSI
    0.06000
    (0.99%)
    6.14000 USD
    P
    PTIX
    -0.05000
    (-7.14%)
    0.65000 USD
    R
    RSI
    -0.270
    (-2.37%)
    11.140 USD
    R
    RXDX
    1.230
    (1.09%)
    113.430 USD
    S
    SGMO
    -0.10000
    (-4.67%)
    2.04000 USD
    V
    VNRX
    -0.05360
    (-7.31%)
    0.68000 USD
    More
News

Title: 180 Life Sciences Corp

Sector: Healthcare
Industry: Biotechnology
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate,combination therapy.